Accuray Incorporated
ARAY- 1M
- -53.3%
Accuray Incorporated in brief
Accuray Incorporated is a listed company in the Medical Devices industry, based in California, USA. It was founded in 1990. Its market value was $17 M on 30 October 2026, which makes it the 24,824th largest listed company in the world and the 4,189th largest in the USA on this site. In the year to June 2026 it had sales of $402 M and a net loss of $49 M. It employs about 995 people and Stephen R. La Neve is its chief executive. By market, the largest shares of its 2026 sales came from EIMEA (38%), Americas (22%) and China (17%). Its shares trade under the symbol ARAY (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Accuray Incorporated
Accuray is Develops, Manufactures and Sells Radiotherapy Systems company for alternative cancer treatments. The company annual revenue is 754.6 million USD and 947 employees as on 2020. The headquarters is in USA.
Accuray Incorporated timeline
- 1990
- 🏁· approximateFounded
- 2002
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2007
- 🔔· approximateInitial public offering on Nasdaq
- 2025
- 💰Record revenue of $458 millionFY2025, the highest of the 9 years on record.
Events of Accuray Incorporated from the company record, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,060 (Jan 2020) · #2,974 (Jan 2021) · #3,188 (Jan 2022) · #3,756 (Dec 2022) · #2,884 (Jul 2023) · #3,031 (Jan 2024) · #2,104 (Mar 2026) · #3,851 (Aug 2026) · #3,961 (Sep 2026) · #4,191 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 0.0×
- Price / book
- 0.4×
- Free cash flow yield
- -76.3%
- Net margin (TTM)
- -4.4%
- Operating margin
- -6.6%
- Return on equity
- -41.7%
- Liabilities / assets
- 90.6%
- Net debt
- $107M
- Revenue growth
- -12.3%
- R&D / revenue
- 9.4%
- Revenue per employee
- $404 K
- Profit per employee
- $-49 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $402M | -12.3% | $-26M | $-49M | -12.2% |
| Jun 2025 | $459M | +2.7% | $8M | $-2M | -0.3% |
| Jun 2024 | $447M | -0.2% | $1M | $-16M | -3.5% |
| Jun 2023 | $448M | +4.1% | $2M | $-9M | -2.1% |
| Jun 2022 | $430M | +8.5% | $8M | $-5M | -1.2% |
| Jun 2021 | $396M | +3.5% | $22M | $-6M | -1.6% |
| Jun 2020 | $383M | -8.6% | $13M | $4M | 1.0% |
| Jun 2019 | $419M | — | $1M | $-16M | -3.9% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Jun 2026 | $-7M | $6M | $-13M | — | — |
| Jun 2025 | $3M | $4M | $-1M | $-0.02 | — |
| Jun 2024 | $-12M | $4M | $-16M | $-0.16 | — |
| Jun 2023 | $16M | $13M | $3M | $-0.10 | — |
| Jun 2022 | $-2M | $5M | $-7M | $-0.06 | — |
| Jun 2021 | $39M | $2M | $36M | $-0.07 | — |
| Jun 2020 | $-1M | $4M | $-5M | $0.04 | — |
| Jun 2019 | $-30M | $4M | $-34M | $-0.19 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $87M (-7.9% on a year earlier), net income $10M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 6, 202610-QQuarterly report · period to Sep 2026
- Nov 4, 20268-KCurrent reportOther events
- Nov 4, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Oct 16, 2026DEF 14AProxy statement
- Oct 13, 20268-KCurrent reportDirectors or officers changed
- Oct 6, 20268-KCurrent reportDirectors or officers changed · Shareholder vote · Other events
- Aug 27, 202610-KAnnual report · period to Jun 2026
- Aug 24, 2026DEF 14AProxy statement
- Aug 19, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Aug 6, 20268-KCurrent reportListing notice
- Jul 29, 20268-KCurrent reportMaterial agreement · Unregistered share sale · Directors or officers changed · Other events
- Jun 4, 20268-KCurrent reportAgreement ended · Regulation FD disclosure
Official filings of Accuray Incorporated with the US Securities and Exchange Commission.
Annual results
- Revenue
- $402 M
- Operating income
- $-26 M
- Net income
- $-49 M
For year ending June-2026 · source: SEC filing
Balance sheet
- Total assets
- $444 M
- Total liabilities
- $402 M
- Total equity
- $42 M
As of June-2026
Top 92 institutional investors in Accuray Incorporated#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | TCW Group Inc | 27,527,916 | +8,585,857 (+45.33%) | 22.91% | $7 M | Nov 10, 2026 |
| 2 | Armistice Capital, LLC | 5,736,000 | 0 (0.00%) | 4.77% | $2 M | Nov 16, 2026 |
| 3 | Neuberger Berman Group LLC | 5,384,817 | -688,846 (-11.34%) | 4.48% | $1 M | Nov 13, 2026 |
| 4 | Weber Capital Management LLC /adv | 4,832,616 | -100,090 (-2.03%) | 4.02% | $1 M | Oct 19, 2026 |
| 5 | Vanguard Capital Management LLC | 4,431,159 | -6,641 (-0.15%) | 3.69% | $1 M | Nov 13, 2026 |
| 6 | BlackRock, Inc. | 2,562,855 | -703,330 (-21.53%) | 2.13% | $1 M | Nov 13, 2026 |
| 7 | Renaissance Technologies LLC | 1,990,284 | -75,000 (-3.63%) | 1.66% | $1 M | Nov 12, 2026 |
| 8 | DAFNA Capital Management LLC | 1,680,508 | 0 (0.00%) | 1.40% | $0 M | Nov 16, 2026 |
| 9 | FMR LLC | 1,595,224 | +219,478 (+15.95%) | 1.33% | $0 M | Nov 10, 2026 |
| 10 | Millennium Management LLC | 1,504,733 | -84,412 (-5.31%) | 1.25% | $0 M | Nov 16, 2026 |
| 11 | Silverback Asset Management LLC | 1,450,000 | 0 (0.00%) | 1.21% | $0 M | Nov 16, 2026 |
| 12 | AQR Capital Management LLC | 1,434,184 | -1,284,848 (-47.25%) | 1.19% | $0 M | Nov 16, 2026 |
| 13 | Geode Capital Management, LLC | 1,273,249 | +83,872 (+7.05%) | 1.06% | $0 M | Nov 6, 2026 |
| 14 | Kovack Advisors, Inc. | 1,125,979 | +75,083 (+7.14%) | 0.94% | $0 M | Nov 13, 2026 |
| 15 | Squarepoint Ops LLC | 906,179 | -542,055 (-37.43%) | 0.75% | $0 M | Nov 9, 2026 |
| 16 | Vanguard Fiduciary Trust Co | 685,262 | 0 (0.00%) | 0.57% | $0 M | Nov 13, 2026 |
| 17 | Silverberg Bernstein Capital Management LLC | 647,915 | -11,000 (-1.67%) | 0.54% | $0 M | Oct 13, 2026 |
| 18 | Tenor Capital Management Company, L.P. | 500,000 | 0 (0.00%) | 0.42% | $0 M | Nov 16, 2026 |
| 19 | State Street Corp | 467,466 | -18,400 (-3.79%) | 0.39% | $0 M | Nov 12, 2026 |
| 20 | UBS Group AG | 442,235 | -1,181,730 (-72.77%) | 0.37% | $0 M | Nov 10, 2026 |
| 21 | Gsa Capital Partners LLP | 415,198 | New | 0.35% | $0 M | Nov 16, 2026 |
| 22 | Tudor Investment Corp Et Al | 392,236 | 0 (0.00%) | 0.33% | $0 M | Nov 16, 2026 |
| 23 | Jpmorgan Chase & Co | 373,552 | -3,143 (-0.83%) | 0.31% | $0 M | Nov 12, 2026 |
| 24 | Goldman Sachs Group Inc | 328,396 | -474,561 (-59.10%) | 0.27% | $0 M | Nov 16, 2026 |
| 25 | Williams & Novak Wealth Management, LLC | 303,330 | +65,100 (+27.33%) | 0.25% | $0 M | Oct 9, 2026 |
Show all 92: investors 26 to 92
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | North Star Investment Management Corp. | 264,620 | 0 (0.00%) | 0.22% | $0 M | Oct 27, 2026 |
| 27 | Northern Trust Corp | 260,674 | -2,885 (-1.09%) | 0.22% | $0 M | Nov 16, 2026 |
| 28 | Assenagon Asset Management S.A. | 255,886 | -152,142 (-37.29%) | 0.21% | $0 M | Oct 15, 2026 |
| 29 | Morgan Stanley | 239,634 | -17,399 (-6.77%) | 0.20% | $0 M | Nov 13, 2026 |
| 30 | Ieq Capital, LLC | 178,505 | -154,762 (-46.44%) | 0.15% | $0 M | Nov 10, 2026 |
| 31 | Barclays PLC | 167,006 | -5,633 (-3.26%) | 0.14% | $0 M | Nov 6, 2026 |
| 32 | Susquehanna International Group, LLP | 119,607 | -705,997 (-85.51%) | 0.10% | $0 M | Nov 16, 2026 |
| 33 | Invesco Ltd. | 115,842 | -2,861 (-2.41%) | 0.10% | $0 M | Nov 12, 2026 |
| 34 | XTX Topco Ltd | 114,066 | -46,833 (-29.11%) | 0.09% | $0 M | Nov 16, 2026 |
| 35 | Wells Fargo & Company/mn | 111,500 | 0 (0.00%) | 0.09% | $0 M | Nov 16, 2026 |
| 36 | HSBC Holdings PLC | 111,442 | 0 (0.00%) | 0.09% | $0 M | Nov 16, 2026 |
| 37 | Qube Research & Technologies Ltd | 99,121 | -248,391 (-71.48%) | 0.08% | $0 M | Nov 13, 2026 |
| 38 | Bank Of America Corp /de/ | 91,315 | -19,299 (-17.45%) | 0.08% | $0 M | Nov 16, 2026 |
| 39 | Simplex Trading, LLC | 84,592 | +75,263 (+806.76%) | 0.07% | $0 M | Nov 4, 2026 |
| 40 | Mariner, LLC | 79,313 | -48,129 (-37.77%) | 0.07% | $0 M | Nov 12, 2026 |
| 41 | Wealth Enhancement Advisory Services, LLC | 52,151 | -42,810 (-45.08%) | 0.04% | $0 M | Oct 13, 2026 |
| 42 | Janney Montgomery Scott LLC | 50,032 | 0 (0.00%) | 0.04% | $0 M | Nov 12, 2026 |
| 43 | Cerity Partners LLC | 49,697 | -55,038 (-52.55%) | 0.04% | $0 M | Nov 13, 2026 |
| 44 | Gabelli Funds LLC | 43,800 | 0 (0.00%) | 0.04% | $0 M | Nov 12, 2026 |
| 45 | Vanguard Global Advisers, LLC | 41,222 | 0 (0.00%) | 0.03% | $0 M | Nov 13, 2026 |
| 46 | Jane Street Group, LLC | 40,694 | -2,099,026 (-98.10%) | 0.03% | $0 M | Nov 12, 2026 |
| 47 | Thrivent Financial for Lutherans | 34,080 | 0 (0.00%) | 0.03% | $0 M | Nov 5, 2026 |
| 48 | JMN Financial LLC | 33,870 | New | 0.03% | $0 M | Nov 10, 2026 |
| 49 | Group One Trading LLC | 29,013 | New | 0.02% | $0 M | Nov 10, 2026 |
| 50 | Fidelis Capital Partners, LLC | 28,047 | New | 0.02% | $0 M | Nov 12, 2026 |
| 51 | Mercer Global Advisors Inc /adv | 25,768 | -26,522 (-50.72%) | 0.02% | $0 M | Nov 16, 2026 |
| 52 | BNP Paribas Financial Markets | 23,768 | -951 (-3.85%) | 0.02% | $0 M | Nov 12, 2026 |
| 53 | Two Sigma Investments, LP | 22,900 | -500 (-2.14%) | 0.02% | $0 M | Nov 16, 2026 |
| 54 | SEI Investments Co | 21,442 | -593 (-2.69%) | 0.02% | $0 M | Nov 10, 2026 |
| 55 | Arax Advisory Partners | 21,353 | -15,208 (-41.60%) | 0.02% | $0 M | Nov 12, 2026 |
| 56 | Captrust Financial Advisors | 21,010 | -17,609 (-45.60%) | 0.02% | $0 M | Nov 12, 2026 |
| 57 | Oppenheimer & Co Inc | 21,000 | 0 (0.00%) | 0.02% | $0 M | Oct 26, 2026 |
| 58 | Teton Advisors, LLC | 18,000 | 0 (0.00%) | 0.01% | $0 M | Nov 12, 2026 |
| 59 | Creative Planning | 16,406 | -26,280 (-61.57%) | 0.01% | $0 M | Nov 2, 2026 |
| 60 | LPL Financial LLC | 15,892 | -18,656 (-54.00%) | 0.01% | $0 M | Nov 6, 2026 |
| 61 | Pallas Capital Advisors LLC | 15,373 | -9,240 (-37.54%) | 0.01% | $0 M | Nov 12, 2026 |
| 62 | Brighton Jones LLC | 14,304 | -13,325 (-48.23%) | 0.01% | $0 M | Nov 3, 2026 |
| 63 | Associated Banc-Corp | 13,675 | 0 (0.00%) | 0.01% | $0 M | Oct 30, 2026 |
| 64 | Merit Financial Group, LLC | 13,471 | -8,930 (-39.86%) | 0.01% | $0 M | Nov 6, 2026 |
| 65 | Integrated Wealth Concepts LLC | 11,832 | -3,206 (-21.32%) | 0.01% | $0 M | Nov 17, 2026 |
| 66 | Tower Research Capital LLC (TRC) | 10,861 | -43,709 (-80.10%) | 0.01% | $0 M | Nov 16, 2026 |
| 67 | BFC Planning, Inc. | 10,240 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 68 | Essential Partners LLC | 5,347 | -2,022 (-27.44%) | 0.00% | $0 M | Oct 14, 2026 |
| 69 | Global Retirement Partners, LLC | 5,188 | -67 (-1.27%) | 0.00% | $0 M | Nov 10, 2026 |
| 70 | Citigroup Inc | 3,609 | New | 0.00% | $0 M | Nov 4, 2026 |
| 71 | EverSource Wealth Advisors, LLC | 2,810 | -1,977 (-41.30%) | 0.00% | $0 M | Nov 4, 2026 |
| 72 | Optiver Holding B.V. | 2,525 | -868 (-25.58%) | 0.00% | $0 M | Nov 16, 2026 |
| 73 | Nuveen, LLC | 2,447 | New | 0.00% | $0 M | Nov 10, 2026 |
| 74 | Rockefeller Capital Management L.P. | 1,879 | +997 (+113.04%) | 0.00% | $0 M | Nov 13, 2026 |
| 75 | Fifth Third Bancorp | 1,826 | +233 (+14.63%) | 0.00% | $0 M | Nov 5, 2026 |
| 76 | Farther Finance Advisors, LLC | 1,422 | -68 (-4.56%) | 0.00% | $0 M | Oct 8, 2026 |
| 77 | Osaic Holdings, Inc. | 1,000 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 78 | Larson Financial Group LLC | 920 | 0 (0.00%) | 0.00% | $0 M | Nov 5, 2026 |
| 79 | True Wealth Design, LLC | 852 | -805 (-48.58%) | 0.00% | $0 M | Oct 13, 2026 |
| 80 | Fairscale Capital, LLC | 479 | 0 (0.00%) | 0.00% | $0 M | Nov 4, 2026 |
| 81 | Fortitude Family Office, LLC | 419 | -220 (-34.43%) | 0.00% | $0 M | Oct 14, 2026 |
| 82 | Steward Partners Investment Advisory, LLC | 400 | New | 0.00% | $0 M | Nov 13, 2026 |
| 83 | Rothschild Investment LLC | 331 | -417 (-55.75%) | 0.00% | $0 M | Nov 10, 2026 |
| 84 | Strategic Financial Concepts, LLC | 229 | New | 0.00% | $0 M | Nov 16, 2026 |
| 85 | Royal Bank Of Canada | 161 | -442 (-73.30%) | 0.00% | $0 M | Nov 16, 2026 |
| 86 | Provenance Wealth Advisors, LLC | 151 | New | 0.00% | $0 M | Oct 30, 2026 |
| 87 | PNC Financial Services Group, Inc. | 125 | -18 (-12.59%) | 0.00% | $0 M | Nov 6, 2026 |
| 88 | SBI Securities Co., Ltd. | 104 | 0 (0.00%) | 0.00% | $0 M | Oct 22, 2026 |
| 89 | HighMark Wealth Management LLC | 100 | 0 (0.00%) | 0.00% | $0 M | Nov 17, 2026 |
| 90 | Hantz Financial Services, Inc. | 25 | 0 (0.00%) | 0.00% | $0 M | Nov 9, 2026 |
| 91 | SJS Investment Consulting Inc. | 25 | -90 (-78.26%) | 0.00% | $0 M | Oct 26, 2026 |
| 92 | Jones Financial Companies Lllp | 24 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
Mutual funds holding Accuray Incorporated#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 3.12 M | $1 M | 2.6% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Neuberger Intrinsic Value FundNeuberger Berman Investment Advisers LLC | 1.41 M | $1 M | 1.2% | 0.04% | −0.1% | May 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 1.19 M | $0 M | 0.99% | <0.01% | −0.4% | Jun 30, 2026 |
| 🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC | 1.19 M | $0 M | 0.99% | <0.01% | +11% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 510,134 | $0 M | 0.42% | <0.01% | +4.0% | May 31, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 471,154 | $0 M | 0.39% | <0.01% | −0.8% | May 31, 2026 |
| 🇺🇸 Column Small Cap Select FundTrust for Professional Managers | 381,882 | $0 M | 0.32% | <0.01% | +0.3% | May 31, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 360,909 | $0 M | 0.30% | <0.01% | −86% | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 181,282 | $0 M | 0.15% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 157,905 | $0 M | 0.13% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC | 143,098 | $0 M | 0.12% | <0.01% | −4.9% | May 31, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 181,931 | $0 M | 0.15% | <0.01% | +525% | Jun 30, 2026 |
| 🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC | 178,351 | $0 M | 0.15% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 92,024 | $0 M | 0.08% | <0.01% | +2.9% | May 31, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 126,442 | $0 M | 0.11% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC | 118,243 | $0 M | 0.10% | <0.01% | −9.5% | Jul 31, 2026 |
| 🇺🇸 Column Small Cap FundTrust for Professional Managers | 64,784 | $0 M | 0.05% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 58,388 | $0 M | 0.05% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 54,348 | $0 M | 0.05% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 73,249 | $0 M | 0.06% | <0.01% | +20% | Jun 30, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 51,997 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 43,049 | $0 M | 0.04% | <0.01% | −83% | Jun 30, 2026 |
| 🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors | 41,571 | $0 M | 0.03% | <0.01% | −23% | Jun 30, 2026 |
| 🇺🇸 BlackRock Advantage SMID Cap Fund, Inc.BlackRock Advisors, LLC | 28,286 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 18,400 | $0 M | 0.02% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 26,157 | $0 M | 0.02% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 TETON Westwood Mighty Mites FundTeton Advisors, LLC | 18,000 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 17,332 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 16,338 | $0 M | 0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 BlackRock Advantage SMID Cap V.I. FundBlackRock Advisors, LLC | 14,060 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors | 12,597 | $0 M | 0.01% | <0.01% | −84% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 5,917 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc. | 5,055 | $0 M | <0.01% | <0.01% | +3.7% | May 31, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 4,663 | $0 M | <0.01% | <0.01% | +8.7% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 3,646 | $0 M | <0.01% | <0.01% | −41% | May 31, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 3,678 | $0 M | <0.01% | <0.01% | −40% | May 31, 2026 |
| 🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors | 4,455 | $0 M | <0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 3,785 | $0 M | <0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 3,510 | $0 M | <0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 2,605 | $0 M | <0.01% | <0.01% | −87% | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 2,754 | $0 M | <0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC | 1,695 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Vanguard Growth And Income FundWellington Management Company LLP | 2,500 | $0 M | <0.01% | <0.01% | −7.4% | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 2,497 | $0 M | <0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 1,691 | $0 M | <0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 JNL/DFA U.S. Core Equity FundJackson National Asset Management, LLC | 647 | $0 M | <0.01% | <0.01% | −89% | Jun 30, 2026 |
| 🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC | 670 | $0 M | <0.01% | <0.01% | −97% | Jun 30, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 916 | $0 M | <0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 620 | $0 M | <0.01% | <0.01% | −85% | Jun 30, 2026 |
| 🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC | 613 | $0 M | <0.01% | <0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc. | 530 | $0 M | <0.01% | <0.01% | −97% | Jun 30, 2026 |
| 🇺🇸 AZL DFA U.S. Core Equity FundAllianz Investment Management LLC | 262 | $0 M | <0.01% | <0.01% | −88% | Jun 30, 2026 |
| 🇺🇸 LVIP Dimensional U.S. Core Equity 2 FundLincoln Financial Investments Corporation | 473 | $0 M | <0.01% | <0.01% | −89% | Jun 30, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 53 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Accuray Incorporated#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Mika NishimuraDirector | Option exercise | +1,415 | — | — | 6,731 | Form 4 |
| filed | James M. HindmanDirector | Option exercise | +1,415 | — | — | 8,785 | Form 4 |
| filed | Steven F. MayerDirector | Option exercise | +1,415 | — | — | 40,055 | Form 4 |
| filed | Joseph E. WhittersDirector | Option exercise | +1,415 | — | — | 18,106 | Form 4 |
| filed | Chan GalbatoDirector | Option exercise | +1,415 | — | — | 2,665 | Form 4 |
| filed | Stephen R. La NeveCEO, Director | Option exercise | +312,500 | — | — | 332,500 | Form 4 |
| filed | Michael John MurphyVP, Corporate Controller | Option exercise | +37,500 | — | — | 62,999 | Form 4 |
| filed | Stephen R. La NeveCEO, Director | Shares withheld for tax | -100,001 | $0.140 | $14 K | 232,499 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Accuray Incorporated#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2026-11-07 00:50 UTC, code T3, resumed 14:00 UTC
Fails to deliver
- : 38,801 shares at $0.14
- : 59,026 shares at $0.13
- : 58,196 shares at $0.13
- : 55,989 shares at $0.14
- : 40,508 shares at $0.16
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Accuray Incorporated scorecard#
Passes 4 of the 20 checks that could be worked out: strongest in valuation (2 of 5), weakest in growth (0 of 5). Fiscal year 2026; market cap of Oct 30, 2026.
Valuation2 of 5
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✓Price to book below its peers' median0.4×Price to book 0.4× against Medical Devices's median of 2.5×.
- ✓Price to sales below its peers' median0.0×Price to sales 0.0× against Medical Devices's median of 2.4×.
- ✗Free cash flow yield above 5%-76.3%Free cash flow is -76.3% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth0 of 5
- ✗Revenue grew in the newest year-12.3%Revenue down 12.3% in fiscal 2026.
- ✗Revenue up more than 5% a year over three years-3.5%-3.5% a year over the three years to fiscal 2026.
- ✗Faster growth over three years than its peers' median-3.5%-3.5% a year against Medical Devices's median of 10.8% (73 companies).
- –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
- ✗Net income higher than five years earlier-$49 M-$49 M in fiscal 2026 against -$6 M in 2021.
- ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2026.
Profitability1 of 5
- ✗Profitable in the newest year-$49 MNet income -$49 M in fiscal 2026.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2026.
- ✓Operating margin above its peers' median-6.6%-6.6% against Medical Devices's median of -8.2% (86 companies).
- ✗Return on equity above 15%-80.1%-80.1% in fiscal 2026.
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-6.6%-6.6% in fiscal 2026 against 0.5% in 2023.
Financial health1 of 5
- ✓Short-term assets cover short-term liabilities1.5×Current ratio 1.50 at the end of fiscal 2026.
- ✗Debt below equity3.5×Debt to equity 3.55 at the end of fiscal 2026.
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-0.8×Operating income -0.8 times interest in fiscal 2026.
- ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2026.
- ✗Altman Z-score outside the distress zone-0.80Z-score -0.80 (distress zone) for fiscal 2026.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2026#
Worked out from Accuray Incorporated's statements, beside the median of Medical Devices.
| Ratio | Trend | 2026 | Median of peers |
|---|---|---|---|
| Operating margin | -6.6% | -8.2% | |
| Net margin | -12.2% | -10.4% | |
| Return on equity | -80.1% | -16.8% | |
| Revenue growth, 3 years a year | -3.5% | 10.8% | |
| Revenue growth | -12.3% | 10.4% | |
| Debt to equity | 3.55× | 0.64× |
1of 9on the Piotroski tests of financial strength
- Revenue fell 12.3% against the year before.
- Net loss of $49 million, the 6th loss-making year in a row.
- Free cash flow was negative: -$13 million.
- Operating income covers the interest bill only -0.8 times.
Accuray Incorporated: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2026to Jun 30, 2026 | FY 2025to Jun 30, 2025 | FY 2024to Jun 30, 2024 | FY 2023to Jun 30, 2023 | FY 2022to Jun 30, 2022 | FY 2021to Jun 30, 2021 | FY 2020to Jun 30, 2020 | FY 2019to Jun 30, 2019 | FY 2018to Jun 30, 2018 | FY 2017to Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 402−12.3%100% | 459+2.7%100% | 447−0.2%100% | 448+4.1%100% | 430+8.5%100% | 396+3.5%100% | 383−8.6%100% | 419+3.4%100% | 405+5.6%100% | 383—100% | |
| Cost of revenue | 290−6.8%72.3% | 312+2.6%67.9% | 304+3.4%68.0% | 294+8.8%65.6% | 270+14.0%62.8% | 237+1.5%59.7% | 233−9.0%60.9% | 256+5.3%61.2% | 243+0.5%60.1% | 242—63.1% | |
| Gross profit | 111−24.2%27.7% | 147+2.8%32.1% | 143−7.2%32.0% | 154−3.7%34.4% | 160+0.3%37.2% | 160+6.5%40.3% | 150−7.9%39.1% | 163+0.6%38.8% | 162+14.4%39.9% | 141—36.9% | |
| Research and development | 38−21.3%9.4% | 48−3.6%10.5% | 50−12.9%11.1% | 57−1.1%12.8% | 58+9.5%13.4% | 53+5.9%13.3% | 50−11.9%13.0% | 56−1.3%13.5% | 57+14.7%14.1% | 50—13.0% | |
| Selling and marketing | 39−10.9%9.6% | 43+1.6%9.4% | 43−7.7%9.5% | 46−7.0%10.3% | 50+16.0%11.6% | 43−9.4%10.8% | 47−15.6%12.3% | 56−6.8%13.4% | 60+4.6%14.8% | 57—15.0% | |
| General and administrative | 45−5.2%11.3% | 48−4.4%10.4% | 50+3.7%11.2% | 48+8.7%10.8% | 44+6.4%10.3% | 42+3.9%10.5% | 40−19.0%10.5% | 50+3.0%11.8% | 48+10.0%11.9% | 44—11.4% | |
| Operating expenses | 138−0.9%34.3% | 139−2.3%30.3% | 142−6.0%31.9% | 152−0.2%33.9% | 152+10.6%35.3% | 137+0.1%34.6% | 137−15.4%35.8% | 162−2.1%38.7% | 165+9.5%40.9% | 151—39.4% | |
| Operating income | −26−437%−6.6% | 7.8+1455%1.7% | 0.5−78.8%0.1% | 2.4−70.8%0.5% | 8.1−63.4%1.9% | 22+77.3%5.6% | 13+2051%3.3% | 0.6—0.1% | −3.8—−0.9% | −9.8—−2.6% | |
| Interest and finance income | 0.8−31.3%0.2% | 1.2−3.2%0.3% | 1.2—0.3% | — | — | — | — | — | — | — | |
| Interest expense and finance costs | 33+154%8.2% | 13+11.4%2.8% | 12+9.3%2.6% | 11+30.8%2.4% | 8.1−51.9%1.9% | 17−6.6%4.3% | 18+19.9%4.7% | 15+0.8%3.6% | 15−13.5%3.7% | 17—4.5% | |
| Provision for credit losses | 0.6—0.1% | −0.1—−0.0% | −0.5—−0.1% | — | — | — | — | — | — | — | |
| Share of profit of associates | 1.1−76.2%0.3% | 4.7+156%1.0% | 1.8−28.5%0.4% | 2.6+967%0.6% | 0.2−72.4%0.1% | 0.9—0.2% | −0.1r13—−0.0% | — | — | — | |
| Other non-operating income (expense) | 5.0+796%1.2% | 0.6—0.1% | −2.5—−0.6% | −1.1r−12—−0.2% | −2.3r−10—−0.5% | −28—−7.0% | −6.7—−1.7% | −15—−3.6% | −19—−4.7% | −19—−4.9% | |
| Income before tax | −47−4266%−11.8% | 1.1—0.2% | −12—−2.6% | −6.8—−1.5% | −2.0—−0.5% | −4.6−180%−1.2% | 5.7—1.5% | −14—−3.4% | −23—−5.7% | −29—−7.4% | |
| Income tax | 1.9−28.6%0.5% | 2.7−26.8%0.6% | 3.7+49.5%0.8% | 2.5−25.5%0.6% | 3.3+90.9%0.8% | 1.8−6.0%0.4% | 1.9−10.7%0.5% | 2.1+138%0.5% | 0.9−15.4%0.2% | 1.0—0.3% | |
| Net income including minority interests | — | −1.6—−0.3% | −16—−3.5% | −9.3—−2.1% | −5.3—−1.2% | −6.3−265%−1.6% | 3.8—1.0% | −16—−3.9% | −24—−5.9% | −30—−7.7% | |
| Net income attributable to shareholders | −49—−12.2% | −1.6—−0.3% | −16—−3.5% | −9.3—−2.1% | −5.3—−1.2% | −6.3−265%−1.6% | 3.8—1.0% | −16—−3.9% | −24—−5.9% | −30—−7.7% | |
| Earnings per share, basic | -0.40—— | -0.02—— | -0.16—— | -0.10—— | -0.06—— | -0.07−275%— | 0.04—— | -0.19—— | -0.28—— | -0.36—— | |
| Earnings per share, diluted | — | -0.02—— | -0.16—— | -0.10—— | -0.06—— | -0.07−275%— | 0.04—— | -0.19—— | -0.28—— | -0.36—— | |
| Shares, weighted average (basic) | 123+19.3%— | 103+4.6%— | 98+3.6%— | 95+3.0%— | 92+0.1%— | 92+2.4%— | 90+2.8%— | 87+3.0%— | 85—— | — | |
| Shares, weighted average (diluted) | — | 103+4.6%— | 98+3.6%— | 95+3.0%— | 92+0.1%— | 92+1.6%— | 91+3.6%— | 87+3.0%— | 85+2.9%— | 82—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 41−29.2%9.2% | 57−16.3%12.2% | 69r69−23.3%14.6% | 89+0.7%18.7% | 89−23.7%18.8% | 116+8.2%24.2% | 108+40.1%21.9% | 77−7.6%17.5% | 83+15.3%21.9% | 72—17.7% | |
| Short-term investments | — | — | — | — | — | — | — | — | — | 24—5.9% | |
| Receivables | 67−19.0%15.2% | 83−9.6%17.7% | 92+23.0%19.6% | 75−20.8%15.6% | 94+10.6%20.0% | 85−5.8%17.8% | 91−19.0%18.5% | 112+69.5%25.5% | 66−9.3%17.4% | 73—17.9% | |
| Inventory | 147+4.3%33.1% | 141+1.9%30.0% | 138−4.7%29.5% | 145+2.0%30.3% | 142+13.0%30.1% | 126−6.3%26.2% | 134+11.2%27.4% | 121+11.3%27.6% | 109+3.3%28.7% | 105—25.8% | |
| Other current assets | 1.1−51.2%0.2% | 2.2r6.5−44.6%0.5% | 4.0+136%0.8% | 1.7r2.5−52.9%0.4% | 3.6r24−83.4%0.8% | 22+1.5%4.5% | 21−12.3%4.3% | 24+55.5%5.5% | 16−18.0%4.1% | 19—4.7% | |
| Current assets | 288−9.4%64.9% | 317−1.8%67.5% | 323−4.4%69.0% | 338−3.7%70.5% | 351−0.5%74.2% | 353−1.3%73.5% | 357+3.9%72.8% | 344+21.1%78.5% | 284−8.0%75.0% | 309—76.0% | |
| Property, plant and equipment | 27−4.7%6.2% | 29+15.7%6.1% | 25+18.4%5.3% | 21+65.0%4.4% | 13+2.9%2.7% | 12−19.7%2.6% | 15−10.4%3.1% | 17−27.7%3.9% | 24+2.8%6.3% | 23—5.7% | |
| Right-of-use (leased) assets | 28−16.9%6.2% | 33−1.9%7.0% | 34+30.6%7.2% | 26+53.9%5.4% | 17−25.4%3.6% | 23−21.4%4.7% | 29−6.3%5.8% | 31—7.0% | — | — | |
| Goodwill | 58+0.2%13.1% | 58+0.2%12.3% | 58−0.0%12.3% | 58−0.3%12.0% | 58−0.2%12.2% | 58+0.4%12.1% | 58r580.0%11.8% | 58r58−0.2%13.2% | 58+0.1%15.3% | 58—14.2% | |
| Other intangible assets | 0−100%0.0% | 0.0−74.6%0.0% | 0.1−71.9%0.0% | 0.2−16.0%0.0% | 0.3−42.5%0.1% | 0.4−34.4%0.1% | 0.7−2.4%0.1% | 0.7−17.3%0.2% | 0.8−14.8%0.2% | 1.0—0.2% | |
| Total assets | 444−5.6%100% | 470+0.3%100% | 469−2.2%100% | 479+1.3%100% | 473−1.5%100% | 480−2.2%100% | 491+12.0%100% | 438+15.7%100% | 379−6.8%100% | 406—100% | |
| Accounts payable | 41+19.2%9.1% | 34−32.0%7.2% | 50+48.3%10.7% | 34+7.7%7.0% | 31+61.0%6.6% | 19−15.8%4.1% | 23−21.8%4.7% | 30+50.1%6.7% | 20+12.6%5.2% | 17—4.3% | |
| Debt due within a year | 1.5−88.2%0.3% | 13+64.2%2.7% | 7.8+35.6%1.7% | 5.7−33.2%1.2% | 8.6+126%1.8% | 3.8—0.8% | — | — | — | 113—27.8% | |
| Current liabilities | 191−0.6%43.1% | 193−1.4%41.0% | 195−1.7%41.7% | 199−4.9%41.5% | 209+8.6%44.2% | 192+5.5%40.1% | 182−5.2%37.1% | 192+13.4%43.9% | 169−40.4%44.7% | 284—70.0% | |
| Long-term debt | 146+18.2%33.0% | 124−24.7%26.3% | 164−4.2%35.1% | 172−0.2%35.8% | 172+1.1%36.4% | 170−10.2%35.4% | 189+18.4%38.6% | 160+21.9%36.5% | 131+154%34.6% | 52—12.7% | |
| Lease liabilities (non-current) | 28−14.5%6.3% | 32+0.3%6.9% | 32+37.2%6.9% | 24+126%4.9% | 10−40.1%2.2% | 17−27.8%3.6% | 24—4.9% | — | — | — | |
| Total liabilities | 402+3.3%90.6% | 389−8.1%82.7% | 424−0.5%90.4% | 426+1.4%88.8% | 420+2.0%88.8% | 411−3.8%85.7% | 427+10.0%87.0% | 388+17.6%88.6% | 330−8.3%87.2% | 360—88.6% | |
| Retained earnings | −568—−128% | −519—−110% | −518—−110% | −502—−105% | −493—−104% | −488—−102% | −482—−98.1% | −486—−111% | −474—−125% | −450—−111% | |
| Shareholders' equity | 42−48.6%9.4% | 81+80.0%17.3% | 45−16.0%9.6% | 54+0.9%11.2% | 53−22.7%11.2% | 69+8.2%14.3% | 64+27.6%13.0% | 50+2.5%11.4% | 49+4.5%12.8% | 47—11.4% | |
| Total liabilities and equity | 444−5.6%100% | 470+0.3%100% | 469−2.2%100% | 479+1.3%100% | 473−1.5%100% | 480−2.2%100% | 491+12.0%100% | 438+15.7%100% | 379−6.8%100% | 406—100% | |
| Shares outstanding | 119+6.0%— | 113+12.4%— | 100+3.8%— | 97+3.2%— | 93+2.9%— | 91−0.4%— | 91+3.0%— | 89+2.8%— | 86+2.9%— | 84—— | |
| Cash-flow statement | |||||||||||
| Depreciation and amortization | 7.9+29.1%2.0% | 6.2+4.1%1.3% | 5.9+30.4%1.3% | 4.5−17.9%1.0% | 5.5−13.7%1.3% | 6.4−15.3%1.6% | 7.5−28.1%2.0% | 10+7.8%2.5% | 9.7−46.1%2.4% | 18—4.7% | |
| Share-based compensation | 6.5−36.7%1.6% | 10+7.6%2.2% | 9.5−5.7%2.1% | 10−5.2%2.2% | 11+13.6%2.5% | 9.3+14.5%2.4% | 8.2−23.1%2.1% | 11−13.7%2.5% | 12−9.8%3.0% | 14—3.6% | |
| Cash from operating activities | −7.0−344%−1.7% | 2.9—0.6% | −12−177%−2.7% | 16—3.5% | −2.4−106%−0.6% | 39—9.7% | −1.5—−0.4% | −30−262%−7.1% | 18—4.5% | −0.4—−0.1% | |
| Capital expenditure | −5.9—−1.5% | −4.3—−0.9% | −3.6—−0.8% | −13—−2.8% | −4.7—−1.1% | −2.3—−0.6% | −3.6—−0.9% | −4.3—−1.0% | −6.3—−1.6% | −5.0—−1.3% | |
| Intangible assets bought | — | — | 0—0.0% | −0.1—−0.0% | 0—0.0% | 0—0.0% | −0.2—−0.0% | — | −0.3—−0.1% | −0.3—−0.1% | |
| Cash from investing activities | −12—−3.1% | −8.5—−1.9% | −3.6—−0.8% | −13—−2.8% | −4.7—−1.1% | −2.4—−0.6% | −3.7—−1.0% | −4.3−124%−1.0% | 18−0.3%4.4% | 18—4.6% | |
| Debt repaid | — | — | — | 0—0.0% | 0—0.0% | −116—−29.3% | 0—0.0% | — | −70—−17.2% | −105—−27.4% | |
| Shares issued | 0.7−59.1%0.2% | 1.6−27.6%0.4% | 2.2+2.1%0.5% | 2.2−43.4%0.5% | 3.9+28.3%0.9% | 3.0—0.8% | — | — | — | — | |
| Shares bought back | — | — | — | 0—0.0% | 0—0.0% | −14—−3.6% | 0—0.0% | — | — | — | |
| Cash from financing activities | 7.0—1.7% | −4.3—−0.9% | −4.0—−0.9% | −2.1—−0.5% | −15—−3.6% | −29−208%−7.3% | 27−6.2%7.0% | 28—6.8% | −27—−6.8% | −55—−14.2% | |
| Exchange-rate effect on cash | — | 1.7—0.4% | −1.4−548%−0.3% | 0.3—0.1% | −5.6−666%−1.3% | 1.0+320%0.2% | 0.2+88.7%0.1% | 0.1—0.0% | −0.3−276%−0.1% | 0.2—0.1% | |
| Change in cash | −13—−3.3% | −8.3—−1.8% | −21−2086%−4.7% | 1.0—0.2% | −28−438%−6.5% | 8.3−61.9%2.1% | 22—5.7% | −5.4−165%−1.3% | 8.3—2.0% | −37—−9.6% | |
| Report | 10-K | 10-K | 10-K/A | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q1 FY2027to Sep 30, 2026 | Q4 FY2026to Jun 30, 2026 | Q3 FY2026to Mar 31, 2026 | Q2 FY2026to Dec 31, 2025 | Q1 FY2026to Sep 30, 2025 | Q4 FY2025to Jun 30, 2025 | Q3 FY2025to Mar 31, 2025 | Q2 FY2025to Dec 31, 2024 | Q1 FY2025to Sep 30, 2024 | Q4 FY2024to Jun 30, 2024 | Q3 FY2024to Mar 31, 2024 | Q2 FY2024to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 395−12.5%100% | 87−7.9%100% | 101*−20.9%100% | 105−7.4%100% | 102−12.0%100% | 94−7.5%100% | 128*−5.0%100% | 113+12.0%100% | 116+8.3%100% | 102—100% | 134*—100% | 101—100% | 107—100% | |
| Cost of revenue | 284−8.8%72.0% | 60−9.7%69.9% | 66*−25.7%65.2% | 80−2.5%75.9% | 78+5.2%76.5% | 67r67−0.2%71.2% | 89*−7.6%69.4% | 82+13.3%72.1% | 74+4.1%63.9% | 67—66.1% | 96*—71.4% | 72—71.3% | 71—66.5% | |
| Gross profit | 111−20.8%28.0% | 26−3.4%30.1% | 35*−10.0%34.8% | 25−20.0%24.1% | 24−42.5%23.5% | 27r27−21.6%28.8% | 39*+1.4%30.6% | 32+8.8%27.9% | 42+16.7%36.1% | 34—33.9% | 38*—28.6% | 29—28.7% | 36—33.5% | |
| Research and development | 34−27.0%8.7% | 7.8−30.4%9.0% | 7.7*−32.8%7.6% | 8.2−23.7%7.8% | 11−21.9%10.4% | 11r11−7.4%11.9% | 11*+20.4%9.0% | 11−1.8%9.5% | 14−10.7%11.7% | 12—11.9% | 9.5*—7.1% | 11—10.8% | 15—14.2% | |
| Selling and marketing | 36−17.9%9.0% | 8.7−25.8%10.0% | 9.6*−16.0%9.5% | 8.4−7.4%8.0% | 8.8−20.4%8.7% | 12r12+0.1%12.5% | 11*+6.7%8.9% | 9.1−11.7%8.0% | 11−2.2%9.6% | 12—11.5% | 11*—8.0% | 10—10.2% | 11—10.6% | |
| General and administrative | 43−9.5%10.9% | 10−18.1%11.9% | 12*−3.0%11.4% | 11+4.3%10.7% | 10−19.0%9.8% | 13r15−1.7%13.4% | 12*+4.0%9.3% | 11−13.3%9.5% | 12−6.0%10.7% | 13—12.6% | 11*—8.5% | 12—12.3% | 13—12.3% | |
| Operating expenses | 162+15.1%41.1% | 63+63.3%72.3% | 30*−14.9%29.3% | 34+12.4%32.8% | 36−4.2%34.9% | 38r38+4.7%40.8% | 35*+9.8%27.2% | 31−9.1%27.0% | 37−6.7%32.0% | 37—36.1% | 32*—23.6% | 34—33.3% | 40—37.2% | |
| Operating income | −52—−13.1% | −37—−42.2% | 5.5*+30.5%5.5% | −9.1−968%−8.7% | −12−346%−11.3% | −11—−12.0% | 4.2*−37.9%3.3% | 1.0—0.9% | 4.7—4.1% | −2.1—−2.1% | 6.8*—5.1% | −4.6—−4.5% | −4.0—−3.7% | |
| Interest and finance income | 0.7−41.6%0.2% | 0.1−51.8%0.2% | 0.1*−58.5%0.1% | 0.2−43.8%0.2% | 0.2−11.5%0.2% | 0.3−10.2%0.3% | 0.3*—0.2% | 0.3—0.3% | 0.3—0.2% | 0.3—0.3% | — | — | — | |
| Interest expense and finance costs | 37+103%9.3% | 12+46.9%13.7% | 8.7*+106%8.6% | 8.4+192%8.1% | 7.7+167%7.5% | 8.1+172%8.6% | 4.2*+45.9%3.3% | 2.9+0.2%2.6% | 2.9−1.3%2.5% | 3.0—2.9% | 2.9*—2.2% | 2.9—2.9% | 2.9—2.7% | |
| Provision for credit losses | −0.1−133%−0.0% | 0−100%0.0% | −0.0*—−0.0% | −0.1*—−0.1% | −0.0*−147%−0.0% | 0.7+181%0.7% | −0.1*—−0.1% | −0.2*—−0.2% | 0.0*—0.0% | 0.2—0.2% | — | — | — | |
| Share of profit of associates | 0.8−84.7%0.2% | 0.1−74.0%0.1% | −0.2*−122%−0.2% | 0.4−82.2%0.4% | 0.5−70.6%0.5% | 0.4—0.5% | 0.9*+9.3%0.7% | 2.3+124%2.0% | 1.6—1.4% | −0.1—−0.1% | 0.8*—0.6% | 1.0—1.0% | −0.4—−0.4% | |
| Other non-operating income (expense) | 5.5—1.4% | 0.1—0.1% | 3.1*+1432%3.1% | 2.4—2.3% | −0.1—−0.1% | −0.4−122%−0.4% | 0.2*—0.2% | −1.3−347%−1.1% | −0.2—−0.2% | 1.8—1.8% | −0.9r7.9*—−0.7% | 0.5r−2.4—0.5% | −1.4r−4.4—−1.3% | |
| Income before tax | −15—−3.9% | 11—12.3% | −1.5*−173%−1.5% | −11—−10.8% | −13−508%−12.9% | −21—−22.6% | 2.1*−46.3%1.6% | −0.8—−0.7% | 3.2—2.8% | −3.3—−3.3% | 3.9*—2.9% | −5.9—−5.8% | −8.7—−8.2% | |
| Income tax | 2.0−22.5%0.5% | 0.5+9.8%0.6% | 0.4*−54.2%0.4% | 0.5+2.4%0.4% | 0.6−17.6%0.6% | 0.5−24.6%0.5% | 0.9*+101%0.7% | 0.5+2.9%0.4% | 0.7−20.8%0.6% | 0.6—0.6% | 0.5*—0.4% | 0.4—0.4% | 0.9—0.8% | |
| Net income including minority interests | — | — | — | — | — | −22—−23.1% | 1.1*−66.8%0.9% | −1.3*—−1.1% | 2.5*—2.2% | −4.0—−3.9% | 3.4*—2.5% | −6.3*—−6.3% | −9.6*—−9.0% | |
| Net income attributable to shareholders | −17—−4.4% | 10—11.7% | −1.9*−273%−1.9% | −12—−11.3% | −14−643%−13.5% | −22—−23.1% | 1.1*−66.8%0.9% | −1.3—−1.1% | 2.5—2.2% | −4.0—−3.9% | 3.4*—2.5% | −6.3—−6.3% | −9.6—−9.0% | |
| Earnings per share, basic | — | 0.07—— | — | -0.09—— | -0.11−467%— | -0.18—— | — | -0.01—— | 0.03—— | -0.04—— | — | -0.06—— | -0.10—— | |
| Earnings per share, diluted | — | 0.07—— | — | — | -0.11−650%— | -0.18—— | — | -0.01—— | 0.02—— | -0.04—— | — | -0.06—— | -0.10—— | |
| Shares, weighted average (basic) | 138+16.2%— | 138+16.2%— | — | 0.1+20.9%— | 0.1+19.3%— | 119r119+118579%— | — | 0.1r103−99.9%— | 0.1r101−99.9%— | 0.1r100—— | — | 99—— | 98—— | |
| Shares, weighted average (diluted) | 139+17.1%— | 139+17.1%— | — | — | 0.1+16.6%— | 119+18.7%— | — | 103+3.7%— | 0.1r104−99.9%— | 100—— | — | 99—— | 98—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 42—10.8% | 42−33.3%10.8% | 41−29.2%9.2% | 38−51.1%8.5% | 41−34.0%9.2% | 63+7.0%13.9% | 57−16.3%12.2% | 78+28.7%16.1% | 63−14.0%13.1% | 59—12.5% | 69r69—14.6% | 60—13.1% | 73—15.3% | |
| Receivables | 50—12.9% | 50−7.4%12.9% | 67−19.0%15.2% | 65−17.4%14.4% | 61−30.1%13.6% | 54−40.8%11.9% | 83−9.6%17.7% | 78+6.9%16.1% | 87+12.8%18.2% | 92—19.4% | 92—19.6% | 73—15.8% | 77—16.2% | |
| Inventory | 146—37.5% | 146−6.1%37.5% | 147+4.3%33.1% | 157+7.0%35.0% | 151+1.4%33.7% | 156+0.4%34.0% | 141+1.9%30.0% | 146−8.2%30.2% | 149−4.1%31.1% | 155—32.7% | 138—29.5% | 160—34.5% | 155—32.6% | |
| Other current assets | 2.5—0.6% | 2.5−65.7%0.6% | 1.1−51.2%0.2% | 2.2−55.3%0.5% | 1.9−58.7%0.4% | 7.3+75.4%1.6% | 2.2r6.5−44.6%0.5% | 4.8+156%1.0% | 4.6+30.9%1.0% | 4.2—0.9% | 4.0—0.8% | 1.9—0.4% | 3.5—0.7% | |
| Current assets | 266—68.2% | 266−12.4%68.2% | 288−9.4%64.9% | 293−12.1%65.5% | 292−10.3%65.3% | 304−7.9%66.5% | 317−1.8%67.5% | 333+6.2%68.9% | 326−1.6%68.1% | 330—69.7% | 323—69.0% | 314—67.9% | 331—69.5% | |
| Property, plant and equipment | 26—6.6% | 26−10.7%6.6% | 27−4.7%6.2% | 29+7.1%6.5% | 29+8.8%6.5% | 29+14.5%6.4% | 29+15.7%6.1% | 27+6.7%5.6% | 27+3.7%5.6% | 25—5.4% | 25—5.3% | 25—5.5% | 26—5.4% | |
| Right-of-use (leased) assets | 26—6.7% | 26−18.6%6.7% | 28−16.9%6.2% | 29−15.1%6.5% | 31−2.9%6.9% | 32−5.0%7.0% | 33−1.9%7.0% | 34+16.8%7.0% | 32+37.3%6.6% | 34r33—7.1% | 34—7.2% | 29—6.3% | 23—4.8% | |
| Goodwill | 23—5.8% | 23−61.1%5.8% | 58+0.2%13.1% | 58+0.3%12.9% | 58+0.3%12.9% | 58r58+0.4%12.7% | 58+0.2%12.3% | 58+0.1%11.9% | 58r58−0.2%12.1% | 58r58—12.2% | 58—12.3% | 58—12.5% | 58—12.1% | |
| Other intangible assets | — | — | 0−100%0.0% | — | 0.0−97.3%0.0% | 0.0−91.7%0.0% | 0.0−74.6%0.0% | 0.0−62.9%0.0% | 0.0−68.1%0.0% | 0.0—0.0% | 0.1—0.0% | 0.1—0.0% | 0.1—0.0% | |
| Total assets | 390—100% | 390−14.6%100% | 444−5.6%100% | 448−7.6%100% | 448−6.3%100% | 457−3.4%100% | 470+0.3%100% | 484+4.7%100% | 478+0.4%100% | 473—100% | 469—100% | 463—100% | 476—100% | |
| Accounts payable | 33—8.5% | 33−22.1%8.5% | 41+19.2%9.1% | 53+14.0%11.8% | 44−19.4%9.7% | 42−14.9%9.3% | 34−32.0%7.2% | 46+4.3%9.6% | 54+37.8%11.3% | 50—10.5% | 50—10.7% | 44—9.6% | 39—8.2% | |
| Debt due within a year | 6.7—1.7% | 6.7−47.9%1.7% | 1.5−88.2%0.3% | 11+47.3%2.5% | 11+47.0%2.5% | 13+65.4%2.8% | 13+64.2%2.7% | 7.6+4.5%1.6% | 7.6+12.2%1.6% | 7.8—1.6% | 7.8—1.7% | 7.2—1.6% | 6.7—1.4% | |
| Current liabilities | 170—43.6% | 170−12.6%43.6% | 191−0.6%43.1% | 206+1.2%46.0% | 199−1.0%44.5% | 195−3.6%42.6% | 193−1.4%41.0% | 203+2.5%42.0% | 201−3.8%42.1% | 202—42.7% | 195—41.7% | 198—42.9% | 209—43.9% | |
| Long-term debt | 95—24.3% | 95−25.4%24.3% | 146+18.2%33.0% | 134−19.4%29.9% | 125−25.7%27.9% | 127−21.6%27.9% | 124−24.7%26.3% | 166−0.0%34.3% | 168−0.0%35.1% | 162—34.3% | 164—35.1% | 166—35.9% | 168—35.3% | |
| Lease liabilities (non-current) | 26—6.8% | 26−16.0%6.8% | 28−14.5%6.3% | 29−13.1%6.5% | 30−0.9%6.7% | 31−3.1%6.9% | 32+0.3%6.9% | 33+18.2%6.9% | 30+40.0%6.4% | 32r32—6.9% | 32—6.9% | 28—6.1% | 22—4.6% | |
| Total liabilities | 337—86.4% | 337−14.7%86.4% | 402+3.3%90.6% | 406−6.6%90.7% | 395−8.3%88.1% | 395−7.7%86.5% | 389−8.1%82.7% | 435+3.1%89.8% | 430+0.4%90.0% | 428—90.4% | 424—90.4% | 421—91.1% | 429—90.0% | |
| Retained earnings | −558—−143% | −558—−143% | −568—−128% | −567—−127% | −555—−124% | −541—−118% | −519—−110% | −520—−107% | −519—−109% | −522—−110% | −518—−110% | −521—−113% | −515—−108% | |
| Shareholders' equity | 53—13.6% | 53−14.1%13.6% | 42−48.6%9.4% | 42−15.9%9.3% | 53+11.5%11.9% | 62+36.8%13.5% | 81+80.0%17.3% | 50+20.7%10.2% | 48+0.5%10.0% | 45—9.6% | 45—9.6% | 41—8.9% | 48—10.0% | |
| Total liabilities and equity | 390—100% | 390−14.6%100% | 444−5.6%100% | 448−7.6%100% | 448−6.3%100% | 457−3.4%100% | 470+0.3%100% | 484+4.7%100% | 478+0.4%100% | 473—100% | 469—100% | 463—100% | 476—100% | |
| Shares outstanding | 120—— | 120+5.6%— | 119+6.0%— | 119+15.6%— | 119+15.5%— | 113+12.8%— | 113+12.4%— | 103+3.6%— | 103+3.7%— | 100—— | 100—— | 99—— | 99—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 8.3+30.4%2.1% | 2.0+20.9%2.3% | 2.0*+26.7%2.0% | 2.1*+31.9%2.0% | 2.2*+43.0%2.1% | 1.7+14.5%1.8% | 1.6*+6.0%1.3% | 1.6*−1.6%1.4% | 1.5*−2.1%1.3% | 1.5—1.4% | 1.5*—1.1% | 1.6*—1.6% | 1.5*—1.4% | |
| Share-based compensation | 5.1−51.2%1.3% | 1.1−55.4%1.3% | 1.7*−40.4%1.7% | 1.4−49.8%1.3% | 0.9−61.4%0.9% | 2.5+6.9%2.7% | 2.8*+38.0%2.2% | 2.7+0.4%2.4% | 2.3−1.3%2.0% | 2.4—2.3% | 2.0*—1.5% | 2.7—2.7% | 2.3—2.2% | |
| Cash from operating activities | −23−203%−5.8% | −3.8−131%−4.4% | 2.4*—2.4% | −5.6*−131%−5.3% | −16*−988%−15.6% | 12—13.0% | −9.7*−198%−7.6% | 18*—15.9% | 1.8*—1.6% | −7.3—−7.2% | 9.9*—7.4% | −8.1*—−8.0% | −5.1*—−4.7% | |
| Capital expenditure | −4.1—−1.0% | −0.1—−0.1% | −0.5*—−0.5% | −0.5*—−0.4% | −3.0*—−3.0% | −1.9—−2.0% | −1.3*—−1.0% | −1.0*—−0.8% | −0.9*—−0.8% | −1.1—−1.1% | −0.5*—−0.3% | −0.8*—−0.8% | −1.2*—−1.2% | |
| Intangible assets bought | — | — | — | — | — | — | — | — | — | — | 0*—0.0% | 0*—0.0% | — | |
| Cash from investing activities | −13—−3.4% | −5.0—−5.8% | −1.4*—−1.3% | −1.5*—−1.4% | −5.6*—−5.5% | −3.8—−4.1% | −3.4*—−2.7% | −2.4*—−2.1% | −1.6*—−1.4% | −1.1—−1.1% | −0.5*—−0.3% | −0.8*—−0.8% | −1.2*—−1.2% | |
| Shares issued | — | — | 0.1*−80.7%0.1% | 0*—0.0% | — | — | 0.8*−13.1%0.6% | 0*—0.0% | — | — | 0.9*—0.7% | 0*—0.0% | — | |
| Cash from financing activities | 18—4.5% | 10—11.9% | 3.6*—3.6% | 4.1*—3.9% | −0.3*−105%−0.3% | −0.5—−0.5% | −5.8*—−4.6% | −2.0*—−1.8% | 5.8*—5.0% | −2.2—−2.1% | −0.7*—−0.5% | −1.5*—−1.5% | −0.3*—−0.2% | |
| Exchange-rate effect on cash | — | — | — | — | — | −0.1−107%−0.1% | 0.8*—0.7% | 1.2*—1.1% | −1.7*−173%−1.5% | 1.3—1.3% | −0.5*—−0.4% | −1.9*—−1.9% | 2.4*—2.2% | |
| Change in cash | −20−322%−5.0% | 1.6−79.3%1.9% | 4.3*—4.3% | −3.4*−123%−3.3% | −22*−618%−21.6% | 7.8—8.3% | −18*−320%−14.2% | 15*—13.1% | 4.3*—3.7% | −9.3—−9.1% | 8.2*—6.1% | −12*—−12.2% | −4.2*—−3.9% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q/A | 10-K/A | 10-Q | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Accuray Incorporated sells: revenue by product line, fiscal 2026#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2025. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Service(total)$229 M57%+3.8%
- Product(total)$173 M43%-27%
Source: SEC annual report (XBRL data) · as of Jun 30, 2026
Where Accuray Incorporated operates: 3 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at Accuray Incorporated#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2026Stephen R. La Neve | $5.2 M | $1.9 M | $738 K | $7 |
| 2025Stephen R. La Neve | $3.0 M | $1.2 M | $1.2 M | $35 |
| 2024Suzanne Winter | $3.5 M | −$126 K | $1.2 M | $47 |
Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2026
Events at Accuray Incorporated#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
Delisting notice 2 · Financial statements withdrawn 1 · Restructuring 1 · Directors and officers 12 · Material agreement 5 · Agreement ended 2 · New debt 1 · Unregistered share sale 3 · Shareholder vote 2 · Results announced 8
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Delisting notice | 8-K | |
| Directors and officersMaterial agreementUnregistered share sale | 8-K | |
| Agreement ended | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Material agreement | 8-K | |
| Directors and officers | 8-K | |
| Financial statements withdrawn | 8-K | |
| Delisting notice | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| RestructuringMaterial agreementUnregistered share sale | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officersMaterial agreementResults announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Directors and officersMaterial agreementAgreement endedNew debtUnregistered share sale | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 4, 2026
Government contracts: Accuray Incorporated#
$1.3 M in federal contracts in fiscal 2026, mostly from Department of Veterans Affairs.
- Department of Veterans Affairs$1.3 M
| Fiscal year | Contracts | Grants |
|---|---|---|
| FY2027 (to date) | $336 K | — |
| FY2026 | $1.3 M | — |
| FY2025 | $5.6 M | — |
| FY2024 | $2.5 M | — |
| FY2023 | $2.4 M | — |
| FY2022 | $1.7 M | — |
| FY2021 | $1.9 M | — |
| FY2020 | $6.3 M | — |
| FY2019 | $10.3 M | — |
| FY2018 | $2.1 M | — |
| FY2017 | $1.7 M | — |
| FY2016 | $10.2 M | — |
| FY2015 | −$2.0 M | — |
| FY2014 | $12.6 M | — |
| FY2013 | $3.0 M | — |
| FY2012 | $1.7 M | — |
| FY2011 | $727 K | — |
Source: USAspending.gov. Obligations are binding promises to pay, not payments, and can be negative when an award is cut. Counted under Accuray Incorporated: ACCURAY INCORPORATED (UEI YHK9MN8BK835)
Lobbying by Accuray Incorporated#
$160 K spent on lobbying the US Congress and federal agencies in 2025, most often on medicare/medicaid and trade (domestic/foreign).
- Medicare/Medicaid4 reports
- Trade (domestic/foreign)4 reports
Lobbying firms hired in 2025
JEFFREY J. KIMBELL AND ASSOCIATES $160 K
| Year | Spending | Own lobbyists | Reports |
|---|---|---|---|
| 2026 (so far) | $120 K | — | 3 |
| 2025 | $160 K | — | 4 |
| 2024 | $160 K | — | 4 |
| 2023 | $160 K | — | 8 |
| 2022 | $190 K | — | 8 |
| 2021 | $250 K | — | 8 |
| 2020 | $240 K | — | 7 |
| 2019 | $160 K | — | 4 |
| 2018 | $160 K | — | 4 |
Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Accuray Incorporated” and “Accuray”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero
H-1B hiring at Accuray Incorporated#
2 labor condition applications certified in fiscal 2026 for 2 positions, at a median wage of $145 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Director Global Prod Strategy Helical Platform & JV ChinaMarketing Managers | 1 | $187 K |
| Manufacturer Process Capability EngineerManufacturing Engineers | 1 | $102 K |
Where: Madison, WI 2
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 2 | 2 | $145 K | 2 |
| FY2025 | 5 | 5 | $157 K | 5 |
| FY2024 | 1 | 1 | $112 K | 1 |
| FY2023 | 8 | 8 | $127 K | 8 |
| FY2022 | 4 | 4 | $126 K | 4 |
| FY2021 | 10 | 10 | $128 K | 10 |
| FY2020 | 7 | 7 | $138 K | 9 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Accuray Incorporated, Accuray Incorporated and Accuray Incorporated
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| 2023 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| 2022 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| 2020 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| 2018 | · | · | · | · | · | · | · | · | · | · | · | · | — |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| 15% of workforce | Restructuring planSEC 8-K | “On December 15, 2025, the Company informed affected employees of such organizational realignment, which resulted in the elimination of approximately 15 percent of the Company’s glo…” | Filing | |
| 5.9% of workforce | Restructuring planSEC 8-K | “On October 25, 2023, the Company informed affected employees of such cost savings initiative, which resulted in the elimination of approximately 5.9 percent of the Company’s global…” | Filing | |
| 4.5% of workforce | Restructuring planSEC 8-K | “On December 1, 2022, Accuray Incorporated (the “Company”) informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of appr…” | Filing | |
| 3% of workforce | Restructuring planSEC 8-K | “On May 27, 2020, Accuray Incorporated (the “Company”) informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of approxim…” | Filing | |
| 5% of workforce | Restructuring planSEC 8-K | “On October 29, 2018, the Company informed affected employees of a cost saving initiative designed to reduce operating costs through the elimination of approximately 5 percent of it…” | Filing | |
| 13% of workforce | Restructuring planSEC 8-K | “On January 3, 2013, in an effort to contain its costs, the Company announced a restructuring of its operations through the elimination of approximately 13 percent of its workforce,…” | Filing |
Source: State WARN notices and SEC 8-K item 2.05
How Accuray Incorporated compares in Medical Devices
- Market cap$17 M · higher than 11% of 142
- Revenue$402 M · higher than 68% of 155
- Net margin-4.4% · higher than 52% of 144
- Revenue growth-12.3% · higher than 8% of 104
- Price / sales0.0× · lowest of 96
- Price / book0.4× · lowest of 99
- FCF yield-76.3% · higher than 8% of 76
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Accuray Incorporated🇺🇸 | $17 M | — | -4.4% | -12.3% |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending June-2026
- Balance sheet:
- As of June-2026
- Employees:
- As on 2021
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Accuray Incorporated? Verify and update this profile — free
Show Accuray Incorporated's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.